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Caspases, a family of apoptotic proteases, are
increasingly recognized as being extensively phos-
phorylated, usually leading to inactivation. To date,
no structural mechanism for phosphorylation-based
caspase inactivation is available, although this infor-
mation may be key to achieving caspase-specific
inhibition. Caspase-6 has recently been implicated
in neurodegenerative conditions including Hunting-
ton’s and Alzheimer’s diseases. A full understanding
of caspase-6 regulation is crucial to caspase-6-
specific inhibition. Caspase-6 is phosphorylated by
ARK5 kinase at serine 257 leading to suppression
of cell death via caspase-6 inhibition. Our structure
of the fully inactive phosphomimetic S257D reveals
that phosphorylation results in a steric clash with
P201 in the L20 loop. Removal of the proline side
chain alleviates the clash resulting in nearly wild-
type activity levels. This phosphomimetic-mediated
steric clash causes misalignment of the substrate-
binding groove, preventing substrate binding.
Substrate-binding loop misalignment appears to be
a widely used regulatory strategy among caspases
and may present a new paradigm for caspase-
specific control.
INTRODUCTION
Caspases are a family of cysteine proteases with exquisite spec-
ificity for cleaving after aspartate residues. Caspases were orig-
inally identified for orchestrating the complex process of
apoptotic programmed cell death. Caspases have since been
found to play a variety of roles in inflammation, differentiation,
and development. Apoptotic caspases are categorized as
initiator (upstream, caspase-2, -8, and -9) or executioner (down-
stream, caspase-3, -6 and -7). Among the apoptotic caspases,
categorization of caspase-6 was historically the most ambig-
uous. Caspase-6 is weakly apoptotic, although overexpression
of caspase-6 does result in apoptosis (Suzuki et al., 2004) simi-
larly to caspase-3 and -7, which are mutually homologous to
caspase-6 (37% sequence identity). Caspase-6 has been
reported to act upstream of the initiator caspase-8 (Cowling
and Downward, 2002) and to be activated by the inflammatory
caspase-1 (Guo et al., 2006), which would set it outside of the742 Structure 20, 742–751, April 4, 2012 ª2012 Elsevier Ltd All rightstraditional executioner caspase category. Together, these
observations suggest that caspase-6 functions in a diversity of
cellular processes, rendering categorization of caspase-6
complex and ambiguous.
Caspase-6 is now known to play important roles in several
neurodegenerative diseases. Caspase-6 cleaves amyloid
precursor protein at position D664 leading to production of the
toxic APP-C31 fragment. Mice in which this caspase-6 cleavage
site is blocked are protected from development of the symptoms
of Alzheimer’s disease (Galvan et al., 2006), suggesting a causal
role for caspase activity. Likewise, cleavage of the polyglut-
amine-expanded Huntingtin protein at a site recognized by
caspase-6 (D586), but not by caspase-3, is required for the
development of the behavioral and neuropathological features
of Huntington’s disease. Substitution of the caspase-6 site in
mice provides protection from the neural dysfunction, suggest-
ing a causal relationship between caspase-6 activity and Hun-
tington’s disease (Graham et al., 2006). Thus, significant interest
exists in full elucidation of the caspase-6 structure, function, and
particularly its regulation, which together give rise to both
apoptotic and neurodegenerative roles.
Due to their cell-death inducing potential, the activities of all
apoptotic caspases are tightly regulated. The regulation of
each caspase is necessarily unique so that each can perform
its independent and nonredundant cellular roles. The most
prevalent mechanisms of caspase regulation include zymogen
activation, binding of inhibitor of apoptosis protein (IAP) family
members, and posttranslational modification. The intersection
of these regulatory pathways may offer especially good thera-
peutic targets.
Many proteases are controlled via zymogen activation, in
which proteolytic processing results in the generation of an
active protease. Caspase zymogens (also called procaspases)
are maintained in a full-length, unprocessed, and inactive form
prior to induction of apoptosis or other activating cellular stimuli.
Processing by an upstream caspase removes a prodomain and
cleaves an intersubunit linker. The mature, active caspase is
a dimer of dimers, composed of two large and two small
subunits. Processing of executioner caspases renders them
active and competent to cleave cellular targets, resulting in
apoptosis. Cleavage of the intersubunit linker produces two
nascent loops that participate in a four-loop substrate-binding
groove bundle. These loops are known to be extremely mobile.
In a number of caspase structures these loops become disor-
dered in the absence of substrate. Locking one of these loops
(L20) into a zymogen-like (down) conformation results in allosteric
inhibition (Hardy et al., 2004; Hardy and Wells, 2009) and can be
used to exogenously inactivate caspase-7 (Witkowski andreserved
Figure 1. S257D Is a Robust Caspase-6 Phosphomimetic
(A) Expression constructs showing accessible cleavage sites (gap) in full-
length (FL) or constitutive two-chain (CT) caspase-6. Protein domains include
the prodomain (gray circle), large subunit (gray bar), intersubunit linker (ISL,
black line), and small subunit (black bar). The phosphomimetic substitution
serine to aspartate is depicted as a white D. Residue numbers for each domain
are indicated. RBS indicates ribosome binding sites for initiation of translation
in the CT constructs.
(B) Cleavage patterns in E. coli expression constructs. Full-length (FL) wild-
type (WT) caspase-6 is self-cleaved to generate large (Lg) and small (Sm)
subunits. The phosphomimetic S257D blocks zymogen processing resulting
in FL and N-terminal pro-domain deleted (DN-FL) proteins. The constitutive
two-chain (CT) variant expresses the large subunit residues 1–179 indepen-
dently of the small subunit, which is expressed from an introduced ribosome-
binding site and a start codon at residue 193. The identity of these bands was
confirmed by mass spectrometry.
(C) Kinetics parameters of caspase-6 variants. Kinetic parameters Km and kcat
were fit from substrate titrations measured from independent duplicate
dilutions of substrate on 3 independent days.
(D) The effect of in vitro caspase-6 phosphorylation by the ARK5 kinase on
caspase-6 activity was measured from independent duplicate dilutions on 3
independent days; error bars represent the standard deviation of those
measurements.
See Figure S1.
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support the L2 loop and as a consequence none of the loops
in the substrate-binding groove bundle (L2, L3, L4, or L20) attain
the proper conformation. In caspase-6 the loops are capable of
a strand-to-helix transition that results in a unique conformation
(Baumgartner et al., 2009; Vaidya et al., 2011), which can not
be obtained by any other caspase (Vaidya and Hardy, 2011).
Caspase-6 is also the only caspase for which autoactivation
has been confirmed and a mechanism of autoactivation has
been elucidated (Wang et al., 2010). In terms of both zymogen
activation and loop control, caspase-6 is distinct from all other
caspases.Structure 20Apoptotic caspases are generally regulated by the IAP family
of inhibitors. The most well studied, XIAP, inhibits caspase-3
and -7, caspase-6’s closest homologs, by binding to the active
site (Chai et al., 2001; Scott et al., 2005). XIAP also inhibits
caspase-9, but does so by blocking self dimerization rather
than active-site binding (Shiozaki et al., 2003). Curiously,
caspase-6 is the only apoptotic executioner caspase resistant
to XIAP-mediated inhibition at either the active site or the dimer
interface (Deveraux et al., 1997; Stennicke et al., 2002). This
could be because caspase-6 exists in the extended helical
conformation or because the intersubunit linker blocks XIAP
active site binding.
Another mechanism of caspase regulation is via posttransla-
tional modification. Phosphorylation is emerging as the most
critical and prevalent form of posttranslational modification
in caspases (for review see Kurokawa and Kornbluth, 2009).
Phosphorylation was first reported to inactivate caspase-9
(Cardone et al., 1998), but has now been discovered to regulate
caspase-2, -3, -6, -7, -8, and -9, although the structural details of
how phosphorylation events activate or inactivate caspases
remain to be discovered. Only a single phosphorylation site
has been reported for caspase-6. Caspase-6 is phosphorylated
at S257 by the kinase ARK5 (Suzuki et al., 2004). ARK5-mediated
phosphorylation results in inactivation of caspase-6, which is
sufficient to suppress Akt-dependent cell death mediated by
the death receptor complex. This single phosphorylation site
in caspase-6 may present an opportunity for understanding
phosphorylation-mediated inhibition of caspases generally.
Phosphorylation occurs in all structural domains of caspases
and typically results in caspase inactivation. Phosphorylation
of the sites of zymogen processing blocks activity by preventing
formation of the active, cleaved caspase (Duncan et al., 2011).
To date no structural information is available to explain how
phosphorylation of other caspase domains results in inactiva-
tion. It remains to be determined whether similar mechanisms
of phosphorylation-based inhibition will emerge or whether
phosphorylation at each site functions using independent
mechanisms. In this study we uncover the structural mechanism
by which caspase-6 phosphorylation results in inhibition.
RESULTS
S257 Phosphomimetics Inactivate Caspase-6
Phosphorylation of capase-6 at residue serine 257 is reported
to inactivate the protein (Suzuki et al., 2004). To study this effect
we made a phosphomimetic version of caspase-6 in which
serine 257 is substituted by aspartate (S257D, Figure 1A).
Substitution of serine by aspartate or glutamate often mimics
the effects of serine phosphorylation due to the introduction
of a negative charge equidistant from the protein backbone.
Caspase-6 is the only caspase for which amolecular mechanism
of autoactivation in cis has been reported (Klaiman et al., 2009),
although other caspases are activated during overexpression in
Escherichia coli, presumably by cleavage in trans. Expression of
full-length (FL) caspase-6 results in self-processing, and forma-
tion of two cleaved fragments, the large and small subunits
that together form active caspase-6 (Figure 1B). Cleavage of
the intersubunit linker, which generates the two-chain form, is
essential for caspase-6 activity (Vaidya et al., 2011). As expected, 742–751, April 4, 2012 ª2012 Elsevier Ltd All rights reserved 743
Figure 2. Circular Dichroism and Mass
Spectrometry Indicate Only Wild-Type Cas-
pase-6 Can Bind Ligand
(A) Thermal denaturation profiles monitored by
circular dichroism of unliganded (APO) and active-
site ligand-bound (VEID-CHO-bound) or (Z-VAD-
FMK-bound) caspase-6 are shown as a function
of temperature. Each condition was measured
in three independently prepared samples on 3
different days, which were used to calculate
average and standard deviations, with represen-
tative curves shown. The increase in the thermal
melting temperature (Tm) indicates that wild-type
but not S257D binds active-site ligand.
(B) The listed molecular weight observed by mass
spectrometry after incubation with the covalent
binding inhibitors Ac-VEID-CHO or Z-VAD-FMK
further indicates that wild-type, but not S257D,
binds ligand at the active site cysteine, C163,
which is in the large subunit.
See Figure S1.
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mature wild-type protein (Figure 1C). Two other S257 variants
were also tested for autoactivation to address whether substitu-
tion at the S257 site in general negatively impacts caspase-6’s
autoactivating ability. The inactivating S257W substitution also
prevented autoactivation, but the S257C substitution, which
has no influence on catalytic efficiency underwent autoactivation
like wild-type (Figure S1A available online), showing that the
ability to autoactivate is a reflection of catalytic competence.
The fact that S257D prevents caspase-6 autoactivation
suggests that phosphorylation of S257 is sufficient to either
prevent catalytic activity or to block zymogen autoactivation.
To test whether phosphorylation of S257 inactivates mature
two-chain caspase-6 or simply blocks zymogen processing,
we introduced S257D into a constitutively two-chain (CT)
caspase-6 expression construct (Vaidya et al., 2011) (Figures
1A and 1B). Two-chain S257D caspase-6 is dramatically inacti-
vated, with a catalytic efficiency nearly three orders ofmagnitude
lower than wild-type caspase-6 (Figure 1C). To ensure that
enzyme concentrations and thus kcat were accurately measured,
the concentration of caspase-6 variants were measured by
active-site titration (Figure S1B). In all cases the concentration
determined by active-site titration agreed well with the concen-
tration based on absorbance at 280 nm. To assess the similarity
between S257D and phosphorylated caspase-6, we incubated
WT caspase-6 or the S257C variant with the kinase ARK5.
Although ARK5 is capable of fully inactivating WT, caspase-6,
it has no effect on the unphosphorylatable S257C variant
(Figure 1D). Thus, the S257D variant is a reliable surrogate for
phosphorylation at S257. This result further suggests that
phosphorylation of S257 is capable of catalytically inactivating
both the zymogen and the mature (cleaved) forms of caspase-6.
Loss of catalytic ability could result from either disruption of
the catalytic machinery or loss of the ability to bind substrate.744 Structure 20, 742–751, April 4, 2012 ª2012 Elsevier Ltd All rights reservedBinding of a substrate-like ligand (VEID-
aldehyde) to caspase-6 results in a shift
in the thermal stability of the liganded
protein (Vaidya et al., 2011). Wild-typecaspase-6 is stabilized by 3C in the presence of the
substrate-like ligands (Figure 2A). The S257D variant is slightly
destabilized relative to wild-type caspase-6, but is still stable
to well above human growth temperatures. In S257D caspase-
6 no increase in thermal stability is observed in the presence of
the substrate-like ligand, suggesting that it is incapable of
binding substrate. The same conclusion can be drawn from
samples analyzed by mass spectrometry (Figure 2B). The
active-site adducts of VEID-aldehyde (VEID-CHO) or the more
general caspase inhibitor z-VAD-FMK, which both bind cova-
lently to the catalytic cysteine in the large subunit were each
observed for wild-type caspase-6 but not for S257D caspase-
6 indicating that S257D prevents binding of substrate. Together
the substrate binding data suggest that S257 phosphorylation
inactivates caspase-6 by preventing substrate binding.
Classically, prevention of substrate binding should be ex-
pected to influence Km. We fit kinetic substrate titrations for
WT and S257D caspase-6 data usingMichaelis-Menten conven-
tions, recognizing that the caspase-6 catalytic mechanism
(Scheme S1) is more complex than can be described by simple
Michaelis-Menten assumptions wherein Km is often viewed as
a surrogate for substrate binding affinity. Due to the fact that
caspase-6 does not function by a standard Michaelis-Menten
mechanism, we report kcat and Km app. Given the complexity of
the caspase-6 reaction mechanism (Scheme S1) we focus on
overall catalytic properties reflected in kcat/Km app and refrain
from interpreting individual changes for kcat or Km app from
a mechanistic viewpoint.
Phosphomimetics Alter Accessibility of the Caspase-6
Intersubunit Linker Suggesting an Altered
Substrate-Binding Groove
One mechanism by which substrate binding could be prevented
by phosphorylation is through disruption of the flexible loops that
Structure
Phosphorylation Inhibits Caspase-6form the caspase-6 substrate-binding groove. In the crystal
structure, the caspase-6 zymogen binds its own intersubunit
linker within the substrate-binding groove (Wang et al., 2010).
This self-binding allows autoactivation at the D193 site but also
prevents caspase-3 from accessing and cleaving D193 cleavage
site. Caspase-6 is efficiently processed by caspase-3 at the
available D179 site and can subsequently be processed at the
D193 site. Measuring susceptibility of caspase-6 to cleavage
by caspases at the intersubunit linker reports the status of the
substrate binding-grooves in wild-type and S257D caspase-6.
If the substrate-binding groove of S257D is in the same confor-
mation as the C163S zymogen, we would expect cleavage of
the two versions of caspase-6 to occur at identical rates. If the
substrate-binding groove is ordered, the D193 site is expected
to be protected from caspase-3 cleavage. Changes in the
substrate-binding groove are expected to alter the accessibility
of the linker to cleavage.
To test this accessibility of the D193 cleavage site, we exam-
ined the ability of caspase-3 to cleave zymogen caspase-6
(C163S) or S257D. The cleavage products were assessed by
comparison to caspase-6 processing variants of known com-
position (D23A D179A, DND179A, and DND179CT) (Vaidya
et al., 2011) (Figure 3A) and were unambiguously identified by
mass spectrometry (Figure 3D). The procaspase-6 zymogen
(C163S), which is catalytically inactive is incapable of self-
processing and is therefore a useful surrogate for assessing
cleavage of caspase-6 by other caspases. Caspase-6 C163S
was first cleaved by caspase-3 at D179, generating Lg2–179
and Sm180–299 (Figure 3A). The large subunit is then further
processed to remove the prodomain (Lg24–179) and finally at
the D193 site in the intersubunit linker resulting in the final
products Lg24–179 and Sm194–299. This pattern is altered in both
order and kinetics for caspase-3 cleavage of S257D. S257D is
first principally cleaved at the D23 site removing the prodomain
and subsequently cleaved at the D179 site (Figures 3A and
3D). As expected, cleavage by caspase-3 did not result in
activation although S257D attained the mature, processed
form (Figure S2). The order of cleavage by caspase-3 was
confirmed with the D179A/S257D variant (Figures S3A and
S3C). As is clearly evident at time points >30 min, cleavage of
the D193 site is much slower in S257D phosphomimetic
than in the C163S zymogen. These differences in order and
kinetics of cleavage by caspase-3 suggest that the substrate-
binding groove of S257D differs structurally from that of active
caspase-6, which has the same loop conformation as the
zymogen.
When catalytically active caspase-6 was incubated with the
zymogen C163S or with phosphomimetic S257D, differences
in patterns of cleavage by active caspase-6 were also observed
(Figure 3B). In both C163S and S257D cleavage first occurred at
the prodomain D23 site and second at the D193 site generating
Lg24–193 and Sm194–299. For the C163S zymogen, subsequent
cleavage at D179 was much slower than cleavage of S257D
at D179 in which more Lg24–179 accumulated over the course
of the experiment. This was also confirmed with the D179A/
S257D variant (Figure S3). Thus the accessibility of the intersu-
bunit linker to caspase-6 also appears to be altered for S257D
further suggesting changes to the substrate-binding loops in
the phosphomimetic variant.Structure 20Caspase-6 has been reported to be a poor substrate of
caspase-9, (Srinivasula et al., 1996) although caspase-9 can
efficiently cleave caspase-7, a canonical caspase-9 substrate
(Figure S4). We reasoned that because phosphorylation alters
the substrate-binding grooves, it might also alter the availability
of caspase-6 to caspase-9 cleavage. For both the C163S and
S257D versions of caspase-6 the only prominent cleavage site
was the D23 prodomain site. Cleavage of zymogen C163S at
D23 was more rapid than S257D. Cleavage at the intersubunit
linker was very slow, however, C163S was cleaved faster than
S257D. For example, at 0.5 hr, 20% more C163S was cleaved
than S257D (Figure 3C). Nevertheless, caspase-9-mediated
cleavage of S257D also differs from zymogen C163S further
underscoring the observation that the substrate-binding groove
of caspase-6 S257D is organized differently than the caspase-6
zymogen.
S257 Phosphomimetic Has a Canonical Caspase Fold,
but Misaligned Substrate-Binding Groove
To determine the status of the substrate-binding groove, we
solved the crystal structure of S257D at 2.87 A˚ resolution. This
structure had eight monomers (here a monomer comprises
one large and one small subunit so there are four full dimeric
caspase-6s with eight active sites present) in the asymmetric
unit. The structure refined to Rcryst/Rfree to 21.5%/25.5% (Table
1). The four dimers in the asymmetric unit are identical, each
representing one functional biological unit. S257D shows the
canonical executioner caspase dimer of dimers, each composed
of a two large and two small subunits. The caspase-6 structures
in the zymogen form, apo mature, VEID-bound, and our phos-
phomimetic S257D variant all exhibit the same core fold (Fig-
ure 4A). Our phosphomimetic variant structure is consistent
with the overall fold of all caspase-6 structures with the excep-
tion of the 60’s, 90’s and 130’s helices elongation from the
mature form but similar to the zymogen and VEID-bound form
(Figure 4B). Structurally our phosphomimetic variant S257D is
located at the base of loop 4 at the dimer interface. There are
several differences around the active site and within the
substrate-binding loops that are unique to our phosphomimetic
variant compared with the other caspase-6 structures (Fig-
ure 4C). Specifically, loops L3 and L4 are in a different conforma-
tion than other caspase-6 structures and loop L20 is folded over
the dimer interface as seen in the apo, mature structures. The
folded conformation of the L20 loop has also been observed in
both the mature and allosterically inactivated caspase-7 struc-
tures. This down conformation does not support the formation
of the substrate-binding groove loop bundle or allow proper
ordering of the L2 loop. The L2 loop is disordered and cannot
be seen in the S257D structure due to the down conformation
of the L20 loop. Three of the four substrate-binding groove loops
are misaligned relative to the active conformation observed
when the substrate mimic VEID is bound to caspase-6 in the
active conformation.
Loop Conformation More Critical for Activity
than Active-Site Geometry
Activity of a caspase or any enzyme requires that the enzyme be
able to bind substrate in the appropriate orientation to facilitate
the chemical reaction and that the amino acid side chains, 742–751, April 4, 2012 ª2012 Elsevier Ltd All rights reserved 745
Figure 3. S257D Cleavage Patterns Suggest a Substrate-Binding Groove that Is Ordered Differently from Wild-Type Caspase-6
(A–C) One percent active caspase-3 (A), 10% caspase-6 (B), or 40% caspase-9 (C) were used. The ratio of active caspase to inactive substrate was selected so
that the same number of units of active caspase-3, -6 or -9 were present in all reactions. The dotted vertical lines indicate the edges of two gels used for analysis.
Gel bands quantified as disappearance of uncleaved full-length procaspase-6 C163S, full-length caspase-6 S257D, or full-length procaspase-7 C186A were
set to 100% or as appearance of cleaved products. Although all bands were measured, only quantification of the large and small subunits are shown, for clarity.
(A) Caspase-3-mediated cleavage of caspase-6 C163S zymogen or S257D phosphomimetic. Control constructs expressing defined domains D23A/D179A, DN
D179A, and DN D179 CT are presented for comparison of the electrophoretic mobility of caspase-6 fragments produced at the indicated time points. Fragments
resulting from caspase-3-mediated cleavage at the 20 min time point were assessed by mass spectrometry to identify precise cleavage sites. Full length (FL), FL
lacking the N-terminal prodomain (DN-FL), large (Lg), and small subunits (Sm) with the amino acids present in those bands (subscripts) are labeled. (B) Caspase-
6-mediated cleavage of caspase-6 C163S zymogen or S257D phosphomimetic are shown at the indicated time points. Fragments resulting from caspase-3-
mediated cleavage at the 2 hr time point were assessed by mass spectrometry to identify precise cleavage sites. Fragment labels are as in (A). (C) Caspase-9-
mediated cleavage of caspase-6 C163S zymogen or S257D phosphomimetic at the indicated time points. Fragment labels are as in (A).
(D) Masses of caspase-6 fragments produced by active caspase-3 or active caspase-6 analyzed by mass spectrometry. Expected molecular weights (MW)
were calculated using the average isotopic masses of the amino acids translated from the DNA sequences of the expression constructs. The N-terminal
methionine was cleaved during bacterial expression, resulting in the presence of Lg2-179. The observed MW were measured after 20 min of cleavage by
caspase-3 or 2 hr of cleavage by caspase-6.
See Figures S2, S3, and S4.
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Table 1. Crystallographic Data Collection and Statistics
Data Collection Statistics
Wavelength (A˚) 1.54
Diffraction resolution (A˚) 50.0–2.8 (2.9–2.8)
Measured reflections (n) 175,642
Unique reflections 47,774
Completeness (%) 90.5 (80.6)
Redundancy 3.7
I/s(I) 27.1/12.6 (2.2)
Rsym 0.134 (0.312)
Space group P21
a (A˚) 81.7
b (A˚) 163.7
c (A˚) 89.0
a = g () 90.0
b () 94.2
Refinement Statistics
No. of atoms 13,944
No. waters 47
Rwork/Rfree (%) 21.5/25.6
RMSD bond length (A˚) 0.005
RMSD bond angle () 0.753
Average B-factor (A˚2) 45.5
Ramachandran Plot
Core (%) 93.8
Allowed (%) 6.2
Disallowed (%) 0
Values in parentheses are for the highest resolution bin. RMSD, root-
mean-square deviation.
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caspase catalysis has not been well studied and remains under
debate. We expect that caspases share a common mechanism
with other cysteine and serine proteases, in which deprotonation
of the catalytic thiol by the histidine in the catalytic dyad
precedes nucleophilic attack. An alternative mechanism has
been also suggested that does not involve catalytic thiol
deprotonation (Fuentes-Prior and Salvesen, 2004). To date, no
caspase structures have been observed with the catalytic
machinery optimally positioned to carry out proton abstraction
preceding the hydrolysis of the peptide bond. All zymogen
structures have been obtained using variants in which the
catalytic nucleophile has been removed by substitution of the
cysteine with alanine or serine, making observation of the cata-
lytically relevant geometry impossible. The majority of caspase
crystal structures have focused on peptide-based inhibitors,
which bind covalently to the active site. Covalent modification
of the active-site cysteine positions the catalytic nucleophile
(C163) over 5 A˚ from the catalytic base (H121), too far for efficient
proton abstraction. The mature apo conformation is unique to
caspase-6 and inactivates by holding the catalytic dyad over
9 A˚ apart in a catalytically incompetent conformation. S257D is
profoundly inactive (Figure 1B) but is the first structure, to our
knowledge, to show reasonable geometry for catalysis (Fig-
ure 4D). Detailed calculations suggest that the optimal heavyStructure 20atom distance for a Cys-his dyad in a cysteine protease is
3.5 A˚ (Podobnik et al., 1997). The active site dyad of S257D is
the only structure that shows optimal geometry and distance
for a proton abstraction mechanism (3.5 A˚). This alignment of
the catalytic machinery is closer than has been observed in
any caspase-6 structure (Figure 4D). Given this finding, the
conformation of the loops seems to be more critical for activity
than the geometry of the catalytic site. Even when the catalytic
dyad is properly positioned, misalignment of the substrate-
binding groove loops is sufficient to fully inactivate caspase-6.
Phosphorylation Mediates Inhibition by Steric Clash
Phosphorylation changes the targeted substrate protein in two
ways: alteration of the electrostatic state and addition of steric
bulk. In structures of other phosphorylated proteins, the addition
of negatively charged phosphates mediate electrostatic inter-
actions with the backbone or with neighboring amino acids
(Hurley et al., 1990; Johnson, 1992; Johnson and Barford,
1994). Phosphorylation of other proteins results in disordering
or reordering elements of secondary structure due to steric
clash. We sought to determine which of these factors played
a role in the inhibition of caspase-6 by phosphorylation at
S257. In the structures of two inhibited forms of caspase-6, the
apo mature form (Figure 5A) and the VEID-aldehyde-bound
form (Figure 5B) positively charged residues are clustered in
the vicinity of S257. The role of electrostatic interactions in
S257D were interrogated by changing the positively charged
neighboring residues R254, R259, K272, and K273 to alanine
or a negatively-charged amino acid. If electrostatic interactions
play a role in inhibition of S257D, these secondary substitutions
would be expected to lessen the impact of the phosphomimetic
S257D substitution, which decreases the activity of caspase-6
by nearly three orders of magnitude (Table 2). Of the double
variants, only the R254D substitution showed any impact on
the kinetics of catalysis. Reversing the charge in R254D returned
one order of magnitude in activity, although no direct interaction
between these residues was observed in the S257D structure.
Together this suggests that perhaps long-range electrostatic
interactions may play a role in S257D inactivation.
Given that removal of positive charges was insufficient to fully
reverse the effects of the phosphomimetic S257D substitution,
we interrogated the role of steric clash in the mechanism of
S257D inhibition (Table 2). Superposition of the S275D structure
with the VEID-bound structure suggests that S257D sterically
clashes with proline at position 201 in the L20 loop (Figures 5C
and 5D). Analysis of the superimposed structures suggested
that this clash might be sufficient to prevent the up (active)
conformation of the L20 loop, which is critical for substrate
binding. The substitution S257C, which does not change the
side-chain size, leads to a fully active enzyme. S257N, which is
isosteric (same size, but uncharged), with S257D also results in
the same three orders of magnitude inhibition as S257D. Intro-
ducing a larger residue, S257W, results in a more severely
impacted enzyme, which is catalytically crippled by four orders
of magnitude. These S257 substitutions suggest that the greater
the steric clash, the more severe the impact. The superposition
of S257D with VEID-bound caspase suggests a direct clash
between S257D and P201. Removal of the proline side chain
by the P201G substitution in the presence of S257D (modeled, 742–751, April 4, 2012 ª2012 Elsevier Ltd All rights reserved 747
Figure 4. Caspase-6 S257D Maintains the
Canonical Core Structure with Misaligned
Loops
(A) Superposition of dimeric caspase-6 structures
highlights conformational changes between
various states: the caspase-6 zymogen (3NR2,
green), apo mature (3K7E, orange), VEID-bound
(3OD5, red), and S257D (3S8E, blue). The boxed
region indicates the substrate-binding region
shown in (B). S257D is shown as gray dots.
(B) Only apo, mature caspase-6 attains the
extended helical state of the 60’s and 130’s
helices. Superposition of caspase-6 structures
allows comparison the 60’s, 90’s and 130’s
helices of the caspase-6 structures (coloring as in
A). 1 Denotes the hinge around which the 90’s
helix pivots by 21 transitioning from the apo,
mature state to all other states.
(C) The substrate-binding groove loops differ
dramatically between various caspase-6 confor-
mational states. Superposition of caspase-6 loops
L2, L3, L4 from chain A of the dimer and L20 from
chain B of the dimer show significantly different
conformations in S257D than in all other caspase-
6 states. Dashed loops represent disordered
regions not observed in the crystal structures.
Coloring is as in (A).
(D) Active site geometry and cysteine-histidine
dyad distances in various states of caspase-6.
Distances between the catalytic cysteine (C163,
sticks) and catalytic histidine (H121, sticks) are
drawn (dashed black line). Coloring is as in (A).
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Phosphorylation Inhibits Caspase-6Figure 5E) results in recovery of nearly full enzyme activity (over
two orders magnitude of activity, Table 2). Thus removal of the
P201 side chain prevents the inhibition that is introduced by
the phosphomimetic S257D indicating that this single steric
clash is the predominant factor in phosphorylation-mediated
inhibition of caspase-6, whereas long-range electrostatics play
a minor role.
DISCUSSION
Our results suggest that phosphorylation of caspase-6 S257 can
block both apoptotic and neurodegenerative functions. Until
recently, a compelling question about the role of caspase-6 in
neurodegeneration was how caspase-6 could be activated in
the nucleus to cleave lamin A or in the cytosol to cleave APP or
huntingtin proteins without inducing apoptosis. The recent
crystal structure of zymogen caspase-6 clearly demonstrates
how caspase-6 bound to its own intersubunit linker can prevent
processing by caspase-3 or -9 and can autoprocess and thus
autoactivate (Wang et al., 2010). Autoprocessing of caspase-6
does not result in apoptosis (Klaiman et al., 2009). Our results
suggest that phosphorylation at S257 can prevent caspase-6
autoprocessing. Thus any nonapoptotic caspase-6-dependant
activity that relies on autoprocessing, such as cleavage of
APP or huntingtin proteins will be blocked by S257 phosphoryla-
tion. The activity of cleaved (activated) caspase-6, which is
responsible for the apoptotic role of caspase-6 is also blocked748 Structure 20, 742–751, April 4, 2012 ª2012 Elsevier Ltd All rightsby S257 phosphorylation. Thus phosphorylation of active
caspase-6 by ARK5 or other kinases will also block both
the apoptotic activity of cleaved caspase-6 and the neurodegen-
erative activities of autoprocessed caspase-6.
Cleavage patterns by caspase-3 and -6 as well as the struc-
ture of S257 reveal that the substrate-binding groove loops of
caspase-6 are misaligned by phosphorylation. In other cas-
pases, the conformation of the substrate-binding groove loops
are also critical for function. In both caspase-1 (Scheer et al.,
2006) and caspase-7 (Hardy et al., 2004; Hardy and Wells,
2009) binding of allosteric inhibitors at the dimer interface alter
the conformation of the substrate-binding groove loops, pre-
venting proper formation of the substrate-binding groove and
inhibiting enzymatic activity. In caspase-7, locking one of the
active-site loops into a different conformation can inactivate
the protein (Witkowski and Hardy, 2009, 2011). In S257D
caspase-6, the geometry of the catalytic dyad is more optimal
than has ever been observed in any caspase structure, yet
S257D is profoundly inactive. Proteolytic activity comprises at
least three necessary components: substrate-binding, optimal
positioning of the catalytic nucleophile relative to the labile
peptide bond, and the presence of an oxyanion hole to stabilize
the transition state. None of these components are sufficient on
their own. The fact that phosphorylation of S257 alters the
substrate-binding loops without any negative impact on the
geometry of the catalytic dyad (Figure 4D) or the oxyanion hole
(Figure S5) supports the idea that the conformation of the bindingreserved
Figure 5. S257 Phosphorylation Blocks Caspase-6 Activity through
Steric Clash with P201
(A and B) S257 is surrounded by positively charged residues (R254, R259,
K272, and K273) in both the apo, mature (A), and in the VEID-bound (B)
structures. These positively-charged residues could participate in electro-
static interactions with the negatively charged phosphate bound to S257.
(C) The L20 loop is held in the up (active) conformation when caspase-6 (red) is
bound by VEID, a substrate mimic, but is observed in the down (inactive)
conformation in the S257D structure (blue).
(D) Proline 201 in the L20 loop in the up conformation in the VEID-bound
structure (red) sterically clashes with the superimposed S257D phosphomi-
metic (blue). This steric clash prevents S257D from attaining the active
conformation of the L20 loop.
(E) The substitution P201G modeled here is predicted to alleviate the steric
clash between S257D and P201 in the active (VEID-bound, red) conformation.
See Figure S5.
Table 2. Kinetics Parameters for Caspase-6 Variants
Demonstrate that Inhibition Is the Result of Steric Clash between
S257D and P201
Km app
(mM)
103 3 kcat
(s1)
105 3 kcat/Km app
(s1/mM)
WT 38 ± 4.3 700 ± 20 1,800
S257D 47 ± 2.1 1.5 ± 0.2 3.2
S257D/R254D 54 ± 3.9 17 ± 1 32
S257D/R254A 37 ± 1.2 2.3 ± 0.1 6.2
S257D/R259E 43 ± 2.1 4.5 ± 0.3 10
S257D/R259A 28 ± 0.2 2.1 ± 0.2 7.5
S257D/K272A 41 ± 0.2 2.3 ± 0.1 5.6
S257D/K273A 37 ± 3.6 5.1 ± 0.1 13
S257C 39 ± 1.8 700 ± 30 1,800
S257N 72 ± 4.0 3.5 ± 0.1 4.9
S257W 31 ± 2.8 0.62 ± 0.03 2.0
S257D/P201G 35 ± 3.0 100 ± 30 290
Substrate titrations to assess Km app and kcat were measured from inde-
pendent duplicate dilutions of substrate on 3 separate days.
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Phosphorylation Inhibits Caspase-6loops is at least as important, if not more important than appro-
priate geometry at the active site.
Loop Misalignment Predicted for Other Caspases
Phosphorylation of S257 disrupts the loops that form the
substrate-binding groove and inactivates caspase-6. We predict
that this mechanism of caspase regulation is present in other
caspases as well. Both initiator and executioner caspases
are extensively regulated by phosphorylation and the majority
of these phosphorylation events result in inactivation of the
caspase (for review see Kurokawa and Kornbluth [2009] and
Lo´pez-Otı´n and Hunter [2010]). The most prevalent sites for
phosphorylation cluster in the large and small subunits (Fig-
ure 6A). In caspase-8 only tyrosine phosphorylation has been
observed whereas all other caspases show serine/threonine
phosphorylation. We predict that phosphorylation of Y448,
which inactivates capase-8 (Jia et al., 2008) at the structurallyStructure 20homologous site functions by a similar mechanism of loop
misalignment. Y448 in caspase-8 sits immediately adjacent
to S257 in caspase-6 (Figure 6B). We predict that Y448 phos-
phorylation would likewise prevent the proper ordering of the
L20 loop and thus prevent substrate binding leading to the
observed loss in activity. In caspase-7, S239 phosphorylation
also leads to inactivation (Li et al., 2011). S239 sits at the bottom
of the L3 loop, which forms the base of the substrate-binding
cleft (Figure 6C). Phosphorylation of this residue is predicted
to prevent the L3 loop from adopting its proper folded and flat-
tened conformation, likewise misaligning the substrate-binding
groove. Our analysis of the locations of caspase phosphorylation
sites suggests that loop misalignment may be one of the
predominant mechanisms of caspase inactivation by phosphor-
ylation. Although blocking access of upstream caspases to the
cleavage sites and preventing zymogen processing is also
a possibility, this may be a relatively rarer mechanism as to
date it has only been observed for caspase-3 (Duncan et al.,
2011). Based on the locations of known sites of caspase phos-
phorylation, misalignment of the substrate-binding groove loops
appears to be a general phenomenon across the family of
apoptotic caspases.
The location of the phosphorylation within the caspase
dictates relevant mechanisms of dephosphorylation. If phos-
phorylation is in the prodomain or intersubunit linker (e.g., phos-
phorylation of S135 in the caspase-8 prodomain or T125 in the
caspase-9 prodomain), inhibition will be relieved by zymogen
activation, which removes these regions. S257 phosphorylation
is in the small subunit, which forms the core of folded caspase-6,
so dephosphorylation must require a phosphatase counteract-
ing ARK5 function. This phosphatase has not yet been identified.
Activating ARK5 or suppressing the counteracting phosphatase
represent two more potential points of intervention for treating
caspase-6-mediated neurodegeneration.
It is striking to us that steric clash between a small number of
atoms on S257 and the side chain of P201 is sufficient to lead to, 742–751, April 4, 2012 ª2012 Elsevier Ltd All rights reserved 749
Figure 6. Phosphorylation Is Predicted to Misalign Active Site
Loops in Many Caspases
(A) Both initiator and executioner caspases are phosphorylated. Phosphory-
lation (℗) occurs at indicated sites in all domains of caspases: prodomain (dark
blue), large subunit (medium blue), linker (gray), and small subunit (light blue).
Interdomain cleavage sites are indicated by arrows. Phosphorylation typically
results in inactivation.
(B) In caspase-8 Y448 phosphorylation leads to inactivation. Structural align-
ment of caspase-6 (blue) with caspase-8 (brown) shows capase-8 Y448
(brown spheres) is immediately adjacent to S257 in caspase-6 (blue spheres).
Y448 phosphorylation is therefore predicted to lead to inhibition through
a similar loop-misalignment mechanism.
(C) In caspase-7 phosphorylation of S239 results in inactivation. Structural
alignment of caspase-6 (blue) with caspase-7 (gray) shows caspase-7 S239
(gray spheres) sitting at the base of the L3 loop. S239 phosphorylation is thus
predicted to disrupt the folded state of L3 and prevent substrate binding.
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Phosphorylation Inhibits Caspase-6full enzyme inactivation. Addition of a phosphate to serine
increases steric bulk by just four additional heavy atoms and
changes serine from neutral to doubly negatively charged
phosphoserine. Phosphorylation sometimes leads to ordering
of regions of the phosphoprotein through electrostatic interac-
tions, particularly with arginine residues (e.g., glycogen phos-
phorylase) (Barford et al., 1991; Johnson, 1992; Johnson and
Barford, 1994). On the other hand, steric clash of the phos-
phate leading to disorder is an equally or more common struc-
tural phenomenon induced by phosphorylation. In isocitrate
dehydrogenase the added phosphate sterically occludes and
electrostatically excludes the negatively charged isocitrate
substrate from the active site (Hurley et al., 1990). In two related
enzymes, a-ketoacid dehydrogenase and pyruvate dehydroge-
nase, phosphorylation leads to steric clash, which in turn
disorders a loop and prevents binding of a partner protein
(Kato et al., 2008; Wynn et al., 2004). Similarly, the steric clash
we observe between phospho-S257 and P201 likewise
prevents ordering of the substrate-binding groove loops that750 Structure 20, 742–751, April 4, 2012 ª2012 Elsevier Ltd All rightsin turn prevents binding substrate. Thus the mechanism we
observe for inhibition of caspase-6 appears to be utilized
across many families of proteins.
We now recognize that the region around S257 is a very
susceptible site. The clash of a phosphate with just three side-
chain atoms is sufficient to misalign an entire substrate-binding
groove. Clashes of just a few atoms, especially in small drug-
like molecules have been observed to propagate to large
changes in structure and function of PTP-1B (Hansen et al.,
2005), Factor VIIa (Dennis et al., 2001; Roberge et al., 2001),
glycogen phosphorylase (Zographos et al., 1997), and many
other proteins. These examples demonstrate that small mole-
cules are able to perform similar functions to that of phosphory-
lation at S257 in caspase-6, namely inducing conformational
changes in proteins. Thus, our results suggest that any protein
or small molecule that locks caspase-6 into the S257 phosphor-
ylated conformation would potentially be useful for treatment of
neurodegenerative diseases in which caspase-6 plays a role.EXPERIMENTAL PROCEDURES
Experimental procedures for all aspects of this article are included as
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tion of caspase-6 variants, caspase-6 expression and purification, caspase-3
and -7 expression and purification, caspase-9 expression and purification,
activity assays, in vitro caspase-6 phosphorylation by ARK5, proteolytic
cleavage by active caspase-3, -6, or -9, mass spectrometry, stability mea-
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